[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

4 clusters · 20 sources · 8 days · First seen · Last updated

ADHD mortality risk and medication safety research

Overview

A large-scale meta-analysis involving approximately 16 million people across 19 observational studies has identified a significant link between attention-deficit/hyperactivity disorder (ADHD) and increased mortality risk. Research indicates that individuals with ADHD face a 70% to 71% higher risk of premature death compared to those without the condition. The elevated risk is driven by several factors: suicide-related deaths showed the highest increase, with reports ranging from 89% to 90% higher risk. Deaths from external causes, such as accidental injuries and trauma, were approximately 55% higher, while deaths from natural causes were 27% more likely. Researchers suggest these risks may stem from impulse control difficulties, challenges with executive function, and difficulties managing chronic health conditions. Additionally, adults with ADHD are nearly three times more likely to experience depression and face higher rates of societal stigma. Specific demographic findings noted that women with ADHD could face a reduction in life expectancy of up to 11 years, while men could face a reduction of up to nine years. However, the analysis suggests that pharmacological treatment may offer protective benefits, with medicated individuals showing a 25% lower risk of death from any cause compared to those not receiving medication. Further research published in JAMA Psychiatry has identified a connection between ADHD and an increased risk of developing mild cognitive impairment or dementia in later life. An analysis of approximately 187,000 adults aged 50 and older found that 6.7% of participants with ADHD were later diagnosed with these conditions, compared to 3.4% of those without ADHD. Researchers emphasized that this does not prove ADHD causes dementia. A recent international study has provided new insights into the safety of ADHD medications.

Entities

University College London · University of Liverpool · JAMA Psychiatry · University of Pittsburgh · JAMA Network Open

Timeline

  1. [HEALTH] 3 sources
    International study examines ADHD medication and self-harm risks

    A large international study suggests that ADHD medication may play a smaller role in self-harm risks than previously thought, noting that the highest risk period occurs before therapy begins.

  2. [HEALTH] 2 sources
    ADHD linked to increased risk of cognitive impairment in aging adults

    A major US study links ADHD to a higher risk of cognitive impairment and dementia in older adults, while research also shows women face significantly later diagnoses than men.

  3. [HEALTH] 8 sources
    ADHD linked to significantly higher mortality risk, study finds

    A meta-analysis of 16 million people reveals that individuals with ADHD face a 71% higher mortality risk, driven largely by suicide and accidental injuries, though medication may reduce this risk.

  4. [HEALTH] 7 sources
    ADHD linked to 71% higher risk of premature death

    A meta-analysis of 16 million people shows ADHD is linked to a 71% higher risk of premature death, though prescription medication may reduce this risk by 25%.

Sources

adhs-deutschland.de · aend.de · gigazine.net · gulfnews.com · ikz-online.de · independent.co.uk · it-boltwise.de · lebardegandi.net · medium.seznam.cz · morgenpost.de · news-medical.net · novice24.net · nursingtimes.net · nypost.com · offthepress.com · raillynews.com · sanfordbehavioralhealth.com · thebeltwayreport.com · uwm.edu · world-today-news.com

This summary has been updated 2 times: see revision history